Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: a randomized clinical utility trial

Table 1 List of Case Types, 3 CPV Cases within Each Type

Case Type	Standard	Standard + Protein-based Assay
A	Evidence-based treatment^a	Assay confirms treatment
B	Evidence-based treatment^a	Assay recommends switch (e.g., AS to AT)
C	Ambiguous treatment course	Assay resolve ambiguity

^aEither AS or AT (depending on individual case) and based on age, PSA, Gleason score, etc

ISSN: 1471-2490